Streetbeat News

Regulatory

ITRM

Iterum Therapeutics has received FDA approval for ORLYNVAH™, the first-ever oral penem for treating uncomplicated urinary tract infections (uUTIs). This marks the first FDA-approved product for Iterum, targeting specific bacteria in adult women with limited treatment options.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 9:03 am

OILU

UCO

USO

XOP

Oil ETFs experienced a significant decline following Israel's military strikes on Iran, with ProShares Ultra Bloomberg Crude Oil (UCO) falling 8.41%, United States Oil Fund LP (USO) dropping 4.69%, SPDR S&P Oil & Gas Exploration & Production ETF (XOP) decreasing 1.81%, and MicroSectors Oil & Gas Exploration & Production 3X Leveraged ETNs (OILU) down 4.54%. Despite the geopolitical tensions, Iran's oil industry remains unaffected.

Portfolio Pulse from Pooja Rajkumari

October 28, 2024 | 9:00 am

BIIB

Biogen presented positive Phase 2 results for Felzartamab in treating IgA Nephropathy, showing stable kidney function and sustained effects. Felzartamab is a potential first-in-class treatment, with Phase 3 development planned.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 7:39 am

DTGHF

VLVLY

Volvo Group and Daimler Truck have signed a binding agreement to form a joint venture aimed at developing a software-defined vehicle platform and truck operating system. This initiative is set to revolutionize the commercial vehicle industry by enhancing safety, comfort, and efficiency. The joint venture will be headquartered in Gothenburg, Sweden, and is expected to be completed by the first half of 2025, pending regulatory approvals.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 7:31 am

CCO

Clear Channel's planned sale of its Spanish business to JCDecaux has been canceled due to regulatory hurdles. The company will continue its operations in Spain and focus on its strategic priorities in America and Airports segments.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 6:46 am

TSLA

Tesla is offering a Cybertruck accessory, an off-road light bar, that customers must install themselves due to legal restrictions on Tesla employees. This comes as Tesla continues to innovate with the Cybertruck, despite facing regulatory challenges.

Portfolio Pulse from Benzinga Neuro

October 28, 2024 | 4:36 am

BTC-USD

El Salvador's President Nayib Bukele is celebrated as the world's most popular leader with high approval ratings, despite some controversies. His leadership, particularly in adopting Bitcoin as legal tender, has been praised by Elon Musk.

Portfolio Pulse from Aniket Verma

October 28, 2024 | 3:51 am

MCD

McDonald's has ruled out beef as the source of an E. coli outbreak linked to its Quarter Pounders, focusing instead on onions. The company plans to resume selling Quarter Pounders without onions in affected areas. Despite challenges, analysts believe the impact on McDonald's stock will be minimal.

Portfolio Pulse from Kaustubh Bagalkote

October 28, 2024 | 2:32 am

AAPL

BABA

NVDA

TSM

This week in AI saw significant developments, including record profits for Nvidia supplier SK Hynix, TSMC's chip found in Huawei's AI product, Chinese AI firms defying US sanctions, Apple's AI ambitions, and Nvidia's new AI model outperforming competitors.

Portfolio Pulse from Benzinga Neuro

October 27, 2024 | 1:00 pm

AAPL

DIS

MASI

TSM

Apple Inc. experienced a week of highs and lows, with record iPhone sales and various legal and regulatory challenges. The U.S. probe into TSMC could impact Apple's chip production, while Disney and Hulu bypassed Apple's App Store fees. Apple also faced skepticism over its new AI system and won a patent dispute against Masimo.

Portfolio Pulse from Benzinga Neuro

October 27, 2024 | 11:00 am